hVIVO is Biotechnology in United Kingdom that focus on challenge study platform business. Founded in 1988. They cover business area such as hVIVO PLC, clinical development service business, multiple human disease model, influenza, HRV, RSV, numerous challenge study, pharmaceutical and biotech company, its main activity, its service, infectious disease, laboratory offering, revenue, client clinical service engagement.
1988
( 36 years old in 2024 )
Challenge Study Platform
-
Queen Mary BioEnterprises (QMB) Innovation Centre
42 New Road
London E1 2AX
England, United Kingdom
Private
hVIVO PLCclinical development service businessmultiple human disease modelinfluenzaHRVRSVnumerous challenge studypharmaceutical and biotech companyits main activityits serviceinfectious diseaselaboratory offeringrevenueclient clinical service engagement
* We use standard office opening hours in near hVIVO's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
HVIVO is Biotechnology business from United Kingdom that founded in 1988 (36 years old in 2024), hVIVO business is focusing on Challenge Study Platform.
hVIVO headquarter office and corporate office address is located in Queen Mary BioEnterprises (QMB) Innovation Centre 42 New Road London E1 2AX England, United Kingdom.
hVIVO was founded in United Kingdom.
In 2024, hVIVO is currently focus on challenge study platform sector.
Above is snippet of Google Trends for "challenge study platform" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with hVIVO, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
